The same mechanisms that create benefits in GLP-1 therapy can also create failure modes, and these failure modes aren't random—they cluster in predictable phenotypes defined by baseline physiology, reserve status, and vulnerability patterns.

causalpending

Speaker

Dr. Amin Dadgar

Evidence Quote

“The same mechanisms that create benefits can also create failure modes. And the failure modes aren't random. They cluster in predictable phenotypes.”

Source

Ozempic & Mounjaro: Same Shot. Opposite Results.— Dr. Amin Hedayat, MD
Created: 8/12/2026, 6:40:36 PM

Your notes

Loading notes...